XHKG2273
Market cap950mUSD
Dec 27, Last price
30.90HKD
1D
-3.44%
1Q
-27.80%
IPO
6.37%
Name
Gushengtang Holdings Ltd
Chart & Performance
P/E
27.49
P/S
2.98
EPS
1.06
Div Yield, %
1.22%
Shrs. gr., 5y
1.17%
Rev. gr., 5y
26.18%
Revenues
2.32b
+43.01%
Net income
252m
+39.45%
CFO
410m
+45.96%
Dividend
Sep 05, 20240.13 HKD/sh
Earnings
Jun 18, 2025
Profile
Gushengtang Holdings Limited, an investment holding company, provides healthcare services and sells healthcare products. It also engages in the wholesale and retail of pharmaceutical products; and provision of investment management and supply chain management services. The company was formerly known as Gushengtang (Cayman) Ltd. and changed its name to Gushengtang Holdings Limited in September 2021. The company was incorporated in 2014 and is headquartered in Guangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 2,323,351 43.01% | 1,624,561 18.40% | 1,372,099 48.28% | |||
Cost of revenue | 2,059,428 | 1,428,524 | 1,412,506 | |||
Unusual Expense (Income) | ||||||
NOPBT | 263,923 | 196,037 | (40,407) | |||
NOPBT Margin | 11.36% | 12.07% | ||||
Operating Taxes | 31,232 | 15,158 | 11,136 | |||
Tax Rate | 11.83% | 7.73% | ||||
NOPAT | 232,691 | 180,879 | (51,543) | |||
Net income | 252,202 39.45% | 180,854 -135.67% | (507,069) 98.27% | |||
Dividends | (89,763) | |||||
Dividend yield | 0.73% | |||||
Proceeds from repurchase of equity | 411,884 | (40,242) | 911,023 | |||
BB yield | -3.35% | 0.33% | -22.30% | |||
| Debt | ||||||
Debt current | 93,274 | 75,632 | 74,936 | |||
Long-term debt | 631,446 | 333,073 | 327,887 | |||
Deferred revenue | 38,745 | 60,648 | ||||
Other long-term liabilities | 87,734 | (52,957) | (66,835) | |||
Net debt | (580,987) | (621,706) | (638,885) | |||
| Cash flow | ||||||
Cash from operating activities | 410,142 | 280,995 | 187,755 | |||
CAPEX | (76,436) | (36,971) | (49,721) | |||
Cash from investing activities | (263,609) | (178,364) | (48,952) | |||
Cash from financing activities | 157,501 | (138,079) | 638,569 | |||
FCF | 128,570 | 154,493 | (1,005,761) | |||
| Balance | ||||||
Cash | 1,331,614 | 1,024,342 | 1,030,704 | |||
Long term investments | (25,907) | 6,069 | 11,004 | |||
Excess cash | 1,189,539 | 949,183 | 973,103 | |||
Stockholders' equity | (1,413,262) | (1,364,521) | (1,537,244) | |||
Invested Capital | 4,177,653 | 3,475,458 | 3,468,529 | |||
ROIC | 6.08% | 5.21% | ||||
ROCE | 9.55% | 9.24% | ||||
| EV | ||||||
Common stock shares outstanding | 244,234 | 239,050 | 115,752 | |||
Price | 50.40 -0.20% | 50.50 43.06% | 35.30 | |||
Market cap | 12,309,393 1.97% | 12,072,019 195.44% | 4,086,062 | |||
EV | 11,729,491 | 11,451,381 | 3,447,694 | |||
EBITDA | 384,079 | 299,726 | 49,378 | |||
EV/EBITDA | 30.54 | 38.21 | 69.82 | |||
Interest | 25,576 | 17,615 | 28,403 | |||
Interest/NOPBT | 9.69% | 8.99% | ||||